Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section

2009

Nov-Dec 2009 edition

  • Infections in the ICU
  • Use of Contraindicated Medications in Dialysis Patients Undergoing PCI
  • Medication-Associated Falls in the Elderly
  • P&T Committee Formulary Action

Sep-Oct 2009 edition

  • H1N1 Influenza
  • UIMC Executive Summary of the Management of Novel Influenza A (H1N1) Virus
  • Emergency Use of Peramivir Approved
  • P&T Committee Formulary Action

Jul-Aug 2009 edition

  • Recent Food and Drug Administration Medication Safety Actions
  • Varenicline, Bupropion, Propoxyphene, TNF blockers
  • Etravirine, Orlistat, Insulin glargine
  • P&T Formulary Update

May-Jun 2009 edition

  • Acetaminophen: recommendations from the FDA Advisory Committee
  • Recombinant human erythropoiesis-stimulating agents and mortality in cancer patients
  • Hospital-acquired pneumonia: risks with acid suppression therapies
  • Updated guidelines for nutrition support in the adult critically ill patient: SCCM and A.S.P.E.N.
  • P&T Committee Formulary Action

Mar-Apr 2009 edition

  • Antiplatelet therapy and GI Risk
  • Update on HIV Opportunistic Infections
  • Aspirin for Primary Prevention
  • Update on PPI and Clopidogrel Interaction
  • P&T Committee Formulary Action

Jan-Feb 2009 edition

  • Intensive Glycemic Control and Cardiovascular Events: An Update
  • The Utilization of Pharmacogenomics in Clinical Practice
  • Dalteparin Use Guideline
  • P&T Committee Formulary Action
Top